Medicare Enrolled

Dr. Anselmo Humaran, MD

Dermatology · Miami, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
11474 QUAIL ROOST DR, Miami, FL 33157
3052322066
In practice since 2006 (19 years)
NPI: 1114038023 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Humaran from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Humaran? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Humaran

Dr. Anselmo Humaran is a dermatology in Miami, FL, with 19 years in practice. Based on federal Medicare data, Dr. Humaran performed 159 Medicare services across 80 unique beneficiaries.

Between the years covered by Open Payments, Dr. Humaran received a total of $12,214 from 23 pharmaceutical and/or device companies across 158 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Humaran is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 159 Medicare services$ $12,214 industry payments

Medicare Practice Summary

Medicare Utilization ↗
159
Medicare services
Bottom 49% in FL for dermatology
80
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~8 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (20-29 min)115$65$110
Annual wellness visit, follow-up28$135$150
Office visit, established patient (30-39 min)16$83$150
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,214
Total received (2018-2024)
Avg $1,745/year across 7 years
Top 2% in FL for dermatology
23
Companies
158
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,214 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$409
2023
$344
2022
$643
2021
$1,493
2020
$628
2019
$3,354
2018
$5,343

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,969
GlaxoSmithKline, LLC.
$1,784
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,737
Sunovion Pharmaceuticals Inc.
$1,086
SANOFI-AVENTIS U.S. LLC
$1,050
Janssen Pharmaceuticals, Inc
$717
Esperion Therapeutics, Inc.
$629
Amgen Inc.
$598
Novo Nordisk Inc
$479
Novartis Pharmaceuticals Corporation
$365
Lilly USA, LLC
$325
Radius Health, Inc.
$202
PFIZER INC.
$184
Takeda Pharmaceuticals U.S.A., Inc.
$149
Inspire Medical Systems, Inc.
$140
Allergan, Inc.
$125
Actelion Pharmaceuticals US, Inc.
$125
Horizon Pharma plc
$124
Regeneron Healthcare Solutions, Inc.
$122
Biohaven Pharmaceutical Holding Company Ltd.
$114
Astellas Pharma US Inc
$90
Merck Sharp & Dohme Corporation
$73
Keystone Dental Inc.
$26
Top 3 companies account for 44.9% of total payments
Associated products mentioned in payments ›
ANORO · ANORO ELLIPTA · Aimovig · Amitiza · BEVESPI AEROSPHERE · BEXSERO · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · CHANTIX · ENTRESTO · EUCRISA · FARXIGA · INSPIRE · INVOKANA · JARDIANCE · LONHALA MAGNAIR · MOVANTIK · MYRBETRIQ · NEXLIZET · NURTEC ODT · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PRIMARY CARE - DISEASE STATE · Prolia · Repatha · SOLIQUA · STEGLATRO · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tresiba · Trintellix · Tymlos · UBRELVY · UPTRAVI · UTIBRON · Utibron · XARELTO · Xultophy 100/3.6
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for dermatology in FL.

Equivalent to $7,682 per 100 Medicare services performed
Looking for a dermatology in Miami?
Compare dermatologys in the Miami area by procedure volume, costs, and industry payment transparency.
Browse dermatologys nearby

Geographic Context

Dermatologys within 10 mi
507
Per 100K population
18.9
County median income
$68,694
Nearest hospital
BAPTIST HOSPITAL OF MIAMI
3.7 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Humaran is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 2%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Humaran experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Humaran performed 115 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Humaran receive payments from pharmaceutical companies?
Yes. Dr. Humaran received a total of $12,214 from 23 companies across 158 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Humaran's costs compare to other dermatologys in Miami?
Dr. Humaran's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Humaran) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →